NakanishiTSE:7716 94 EBITDA Margin % is -8.43% as of Dec. 2025. GuruFocus rates TSE:7716 with a GF Score™ of 94/100 and a GF Value™ of 円3,266.03 (Fairly Valued). The stock has 8 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Nakanishi ranks better than 64.22% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nakanishi's EBITDA for the
three
months ended in Dec. 2025 was 円-1,890 Mil. Nakanishi's Revenue for the
three
months ended in Dec. 2025 was 円22,426 Mil. Therefore, Nakanishi's EBITDA margin for the quarter that ended in Dec. 2025 was -8.43%.
Nakanishi (TSE:7716) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Nakanishi EBITDA Margin % Related Terms
Nakanishi EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Nakanishi's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7716 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Nakanishi's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nakanishi EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nakanishi's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Nakanishi's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nakanishi (TSE:7716) has a EBITDA Margin % of -8.43% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nakanishi and its competitors. Over the past decade, Nakanishi's EBITDA Margin % has ranged from 11.44 to 54.06. According to the industry distribution chart, Nakanishi ranks #292 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 35.8%.
Is Nakanishi's EBITDA Margin % too high?
Nakanishi's current EBITDA Margin % is -8.43%. Over the past 10 years, this metric has ranged from a low of 11.44 to a high of 54.06. Based on the distribution chart, Nakanishi ranks #292 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nakanishi has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nakanishi's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nakanishi ranks #292 out of 816 companies for EBITDA Margin %. This puts Nakanishi in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Historically, Nakanishi's own EBITDA Margin % has ranged from 11.44 to 54.06 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nakanishi and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nakanishi's current EBITDA Margin % is -8.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nakanishi stock overvalued right now?
Based on GuruFocus' analysis, Nakanishi (TSE:7716) is currently considered Fairly Valued. The stock's GF Value™ is 円3,266.03, compared to a current price of 円2,989.00 — trading 8.5% below its estimated fair value. The current EBITDA Margin % is -8.43%. Nakanishi's overall GF Score™ is 94/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nakanishi (TSE:7716), the current EBITDA Margin % is -8.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nakanishi (TSE:7716) Overvalued in 2026?
Based on GuruFocus' analysis, Nakanishi stock appears to be undervalued.
The current stock price of 円2,989.00 is trading 8.5% below its estimated GF Value™ of 円3,266.03.
GuruFocus considers Nakanishi to be Fairly Valued.
Key valuation signals for TSE:7716:
EBITDA Margin %: -8.43%
GF Value™: 円3,266.03 vs. price of 円2,989.00 (8.5% below fair value)
No single metric tells the full story. See the TSE:7716 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nakanishi Inc manufactures high-speed rotary cutting technology for the dental industry and the medical industry more broadly. The company distributes its products to countries internationally, earning its key revenue overseas. The company operates via three business segments. The dental product segment manufactures and sells handpieces for dental treatment, mechanical micro motors and handpieces as well as handpieces for surgeries. The surgical business segment manufactures and sells grinders for manual works and spindles for machinery attachment. The Machinery business segment provides inspection and repair services for its dental and medical equipment and general industrial cutting and grinding equipment.
94GF Score
Get the complete analysis for TSE:7716
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7716 has been successfully added to your 
